UKRI's £52m bet: can five hubs move diagnosis out of hospitals?

On 6 November 2026, UK Research and Innovation announced over £52 million in government funding for five new research and partnership hubs developing health technologies. The hubs are led by universities in Exeter, London, Southampton and Sunderland. They target brain health and dementia, traumatic brain injury, cardiovascular disease, diabetes and respiratory infections.

Industry and charity partners are contributing a further £37.5 million in cash and in-kind support. That brings the total programme value to more than £89 million. The co-funding structure matters: public money is being used to leverage private and charitable investment in medtech.

The UK's first network of NHS brain health clinics would use AI with blood tests, brain scans and memory assessments to speed diagnosis by up to 50%. There are pitch-side and car-crash head injury tools. AI eye scans for diabetes and heart disease. Smartphone and wearable tools for respiratory infections.

The Southampton-led CRISP hub receives £10 million and focuses on respiratory infections using wearable sensors, smartphone tools and at-home tests. The Sunderland-based NORI hub is a £12.2 million programme, with £9.1 million from UKRI and £3.1 million from other partners, using eye imaging and health data.

Science minister Chris McDonald said earlier diagnosis means better outcomes for patients and less pressure on the NHS. That is the stated aim.

The policy direction is clear: move detection out of acute hospital settings and into communities. That is the ambition, not a proven outcome.

For now, the structure of the bet is what is known: five hubs, £52 million in public money, £37.5 million in partner contributions, and a stated goal of easing NHS pressure by detecting disease earlier.